SELLAS Life Sciences (SLS) EBIT Margin Growth (1y) (2013 - 2022)
SELLAS Life Sciences (SLS) EBIT Margin Growth (1y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -163,411.00 |
| Jun 30, 2015 | 40,852.00 |
| Mar 31, 2015 | 22,121.00 |
| Dec 31, 2014 | -8,432.00 |
| Sep 30, 2014 | -22,679.00 |
| Jun 30, 2014 | -33,449.00 |
| Mar 31, 2014 | -24,105.00 |
| Dec 31, 2013 | -69,581.00 |
| Sep 30, 2013 | 4,698.00 |